Improving Psychological Outcomes for Acute Respiratory Failure Survivors Using a Self-Management Intervention
This study is looking at a behavioral therapy called cognitive behavioral therapy based self-management for anxiety. This therapy aims to help people who have had acute respiratory failure (ARF), which is when your lungs can't get enough oxygen into your blood, and needed a breathing machine for more than 24 hours. Many people who survive a serious illness like this can have long-lasting anxiety. This study wants to see if this therapy, which teaches you how to manage anxiety, can help reduce anxiety symptoms while you are still in the hospital. We are also checking if the therapy is practical and acceptable for patients. We plan to include 60 participants. The study status is currently unclear.
- Study design
- This is an interventional study that plans to enroll 60 participants. It is a pilot randomized controlled trial, meaning participants will be assigned by chance to either receive the intervention or usual care.
- What's involved
- Participants will take part in cognitive behavioral therapy informed self-management sessions. The primary outcomes are measured at 5 weeks post-enrollment.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will have a 3-month phone-based follow-up after hospital discharge.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Improving Psychological Outcomes for Acute Respiratory Failure Survivors Using a Self-Management Intervention
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Megan Hosey, PhD · PRINCIPAL_INVESTIGATOR · Johns Hopkins School of Medicine
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Treatment Satisfaction Questionnaire5 weeks post-enrollment
Treatment Satisfaction Questionnaire (TSQ) ranges from 0-21, with higher scores representing greater satisfaction. Items (e.g., "useful", "liked it," "perceived symptom improvement") are scored based on a Likert scale, ranging from 0= "not at all" to 7= "very much so." Higher scores indicate higher satisfaction
- average accrual rate of 2 patients/month across all patients3 years
treatment feasibility objective
- treatment feasibility as assessed by sessions completed5 weeks post enrollment
treatment feasibility as assessed by \>70% of intervention sessions completed
- treatment feasibility as assessed by drop out rate3 years
treatment feasibility as assessed by \<15% drop-out across intervention arm